10x Genomics Inc

Financials

Cash from operating activities 5.18 M-6.75 M34.35 M17.71 M43.21 M40.78 M 136.05 M Cash from investing activities -3.62 M13.67 M1.89 M939 K8.8 M1.8 M 13.44 M Cash from financing activities 156 K4.52 M422 K3.52 M617 K2.24 M 6.8 M Free cash flow 1.29 M-9.46 M32.46 M16.13 M42.53 M39 M 130.12 M

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

TXG

Financials

10x Genomics Inc

Haberler

Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%

加拿大股市上涨；截至收盘加拿大多伦多S&P/TSX 综合指数上涨0.61%

Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?

Priceline, Carvana, DoorDash and more set to report earnings Wednesday

10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript

Canaccord Genuity上调10X Genomics目标价至22美元，此前为20美元

10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity

Applied Materials and Rivian among market cap stock movers on Friday

Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics

10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates

10X Genomics面临新定价策略首次亮相的盈利考验

10X Genomics faces earnings test as new pricing strategy debuts